生物技术公司泰克尼(Techne Corporation,TECH)今日盘中股价大涨9.28%,引发市场热议。盘中最高曾上涨10.2%,市值约为128亿美元。
消息透露,该公司刚公布的2025财年第二季度业绩超出市场预期。业绩显示,泰克尼本季度每股收益为0.42美元,高于分析师一致预期的0.39美元;营收则达到2.97亿美元,也超出分析师2.86亿美元的预期。
据了解,推动泰克尼业绩向好的主要原因是其蛋白质科学部门表现出色。该部门专门从事开发用于生物科研、基因治疗等领域的蛋白质相关产品,季度销售额同比增长7%,达到2.116亿美元。生物科技和生命科学行业的需求改善大大激发了这一子板块的业务增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.